Our Services
Medical Information
Helpful Resources
Published on: 9/14/2026
Yes, Cymbalta (duloxetine) can cause dizziness, lightheadedness, and orthostatic hypotension, which raises the risk of falls and fractures in older adults, especially during the first weeks of treatment, after dose increases, or when stopping the medication. Seniors may face added risk from age-related changes in blood pressure regulation, low sodium levels (hyponatremia), sedation, and interactions with other drugs like blood pressure medications, sedatives, or other antidepressants. Warning signs that deserve prompt attention include fainting, unsteady walking, confusion, blurred vision, or a fall of any kind. Several factors influence how likely this is for any one person, including dose, kidney or liver function, and other conditions, so see below to understand the full picture before making any changes.
If you or someone you care for is feeling dizzy, unsteady, or has recently fallen while taking duloxetine, do not stop the medication abruptly, as withdrawal symptoms can include dizziness of their own. A free, instant, online symptom check can help you sort out whether your dizziness fits a medication side effect, a blood pressure problem, or something else entirely, and it points you toward the right next step and the right type of clinician in just a few minutes.
Last reviewed for medical accuracy: 09/13/2026
Can Cymbalta cause dizziness or falls in seniors?
Cymbalta (generic name: duloxetine) is a commonly prescribed antidepressant and pain-relief medication in older adults. While it can effectively manage depression, anxiety and certain types of chronic pain, it also carries a risk of side effects—dizziness and falls being among the most concerning for seniors. This article reviews what the research and prescribing information tell us, why seniors are particularly vulnerable, and practical steps to reduce risk without causing unnecessary alarm.
As we age, normal changes in our bodies make side effects more pronounced:
According to the U.S. Prescribing Information and clinical studies:
Dizziness can feel like lightheadedness, unsteadiness or a sensation that the room is spinning (vertigo). Even mild dizziness can lead to missteps, increasing the chance of a fall.
Falls are rarely caused by a single factor. With Cymbalta, several mechanisms may combine:
Orthostatic hypotension.
Sedation or drowsiness.
Hyponatremia (low sodium).
Drug interactions.
When considering Cymbalta, it’s important to recognize other factors that may heighten fall risk:
Practical strategies can help seniors stay steady while benefiting from Cymbalta’s effects:
Start low, go slow.
Ask your doctor about beginning at a lower duloxetine dose and increasing gradually.
Monitor blood pressure.
Check it lying down, then sitting, then standing. Note any significant drops (more than 20 mm Hg systolic).
Stay hydrated and maintain salt balance.
Drink adequate fluids unless otherwise directed; discuss salt intake with your doctor.
Stand up carefully.
– Sit at the edge of the bed or chair for a minute before rising.
– Rise slowly, holding onto stable furniture or railings.
Wear supportive footwear.
Choose non-slip, low-heeled shoes. Avoid socks on smooth floors.
Improve home safety.
– Secure rugs with non-slip backing.
– Use nightlights, especially in bathrooms and along walkways.
– Install grab bars by toilets and in showers.
Review all medications.
Have a pharmacist or doctor assess for interactions or other drugs that may cause dizziness.
Perform gentle balance exercises.
Tai chi, seated leg raises or standing behind a chair exercises can strengthen balance over time.
If you notice new or worsening dizziness, lightheadedness or unsteadiness while on Cymbalta:
Although most episodes of dizziness are not life-threatening, certain warning signs require prompt medical attention:
If you experience any of the above, call emergency services or go to the nearest emergency department. Always speak to your doctor about anything that could be life threatening or serious.
Cymbalta can improve quality of life for many seniors by alleviating symptoms of depression, anxiety or chronic pain. However, awareness of dizziness and fall risk is crucial. Through careful monitoring, dose adjustments and lifestyle modifications, most seniors can safely take Cymbalta while minimizing the chance of stumbles or injuries.
Next steps:
Your health and safety come first. With the right precautions, you can make an informed decision about using Cymbalta and maintain your independence at home.
(References)
* Jacob J, Albert D, Heard K. Single-agent duloxetine ingestions. Hum Exp Toxicol. 2013 Apr;32(4):427-33. doi: 10.1177/0960327112462726. Epub 2012 Oct 30. PMID: 23111877.
* Shelton RC. Serotonin and Norepinephrine Reuptake Inhibitors. Handb Exp Pharmacol. 2019;250:145-180. doi: 10.1007/164_2018_164. PMID: 30838456.
* Popova V, Daly EJ, Trivedi M, Cooper K, Lane R, Lim P, Mazzucco C, Hough D, Thase ME, Shelton RC, Molero P, Vieta E, Bajbouj M, Manji H, Drevets WC, Singh JB. Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study. Am J Psychiatry. 2019 Jun 1;176(6):428-438. doi: 10.1176/appi.ajp.2019.19020172. Epub 2019 May 21. PMID: 31109201.
* Fedgchin M, Trivedi M, Daly EJ, Melkote R, Lane R, Lim P, Vitagliano D, Blier P, Fava M, Liebowitz M, Ravindran A, Gaillard R, Ameele HVD, Preskorn S, Manji H, Hough D, Drevets WC, Singh JB. Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1). Int J Neuropsychopharmacol. 2019 Oct 1;22(10):616-630. doi: 10.1093/ijnp/pyz039. PMID: 31290965; PMCID: PMC6822141.
* Şahan E, Parlakkaya Yıldız FB. Duloxetine Induced Hyponatremia. Turk Psikiyatri Derg. 2019 Winter;30(4):287-289. PMID: 32594491.
* Tesfaye S, Sloan G, Petrie J, White D, Bradburn M, Julious S, Rajbhandari S, Sharma S, Rayman G, Gouni R, Alam U, Cooper C, Loban A, Sutherland K, Glover R, Waterhouse S, Turton E, Horspool M, Gandhi R, Maguire D, Jude EB, Ahmed SH, Vas P, Hariman C, McDougall C, Devers M, Tsatlidis V, Johnson M, Rice ASC, Bouhassira D, Bennett DL, Selvarajah D, OPTION-DM trial group. Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial. Lancet. 2022 Aug 27;400(10353):680-690. doi: 10.1016/S0140-6736(22)01472-6. Epub 2022 Aug 22. PMID: 36007534; PMCID: PMC9418415.
* Kishi T, Ikuta T, Sakuma K, Okuya M, Hatano M, Matsuda Y, Iwata N. Antidepressants for the treatment of adults with major depressive disorder in the maintenance phase: a systematic review and network meta-analysis. Mol Psychiatry. 2023 Jan;28(1):402-409. doi: 10.1038/s41380-022-01824-z. Epub 2022 Oct 17. PMID: 36253442; PMCID: PMC9812779.
* Zhao Q, Fu B, Lyu N, Xu X, Huang G, Tan Y, Xu X, Zhang X, Wang X, Wang Z, Li K, Hu Z, Li H, He H, Li S, Zhao J, He R, Guo H, Li Y, Li L, Yang C, Zou S, Wei B, Wang W, Chen C, Lu Z, He S, Wang Q, Zhao J, Pan X, Pan Z, Li J, Wang G. A multicenter, randomized, double-blind, duloxetine-controlled, non-inferiority trial of desvenlafaxine succinate extended-release in patients with major depressive disorder. J Affect Disord. 2023 May 15;329:72-80. doi: 10.1016/j.jad.2023.02.067. Epub 2023 Feb 20. PMID: 36813043.
* Yaukey J, Kaur D. Management of Small Fiber Neuropathy: A Clinical Perspective. Muscle Nerve. 2026 Mar;73(3):380-384. doi: 10.1002/mus.70086. Epub 2025 Dec 10. PMID: 41367223.
* Shen YC, Hung CC. Psychiatry Clin Psychopharmacol. 2025 Nov 13. doi: 10.5152/pcp.2025.251248. Epub 2025 Nov 13. PMID: 41562591.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.